These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 33725982

  • 1. Atypical hemolytic uremic syndrome and acute tubular necrosis induced by complement factor B gene (CFB) mutation: A case report.
    Wu H, Su S, Li L, Zhang L.
    Medicine (Baltimore); 2021 Mar 19; 100(11):e25069. PubMed ID: 33725982
    [Abstract] [Full Text] [Related]

  • 2. A complement factor B mutation in a large kindred with atypical hemolytic uremic syndrome.
    Funato M, Uemura O, Ushijima K, Ohnishi H, Orii K, Kato Z, Yamakawa S, Nagai T, Ohara O, Kaneko H, Kondo N.
    J Clin Immunol; 2014 Aug 19; 34(6):691-5. PubMed ID: 24906628
    [Abstract] [Full Text] [Related]

  • 3. [Complement factor B mutation in atypical hemolytic uremic syndrome. Rare cause of rare disease].
    Visconti L, Cernaro V, Ardissino G, Sgarbanti M, Ferrara D, Visconti G, Santoro D, Buemi M.
    G Ital Nefrol; 2017 Apr 19; 34(2):74-81. PubMed ID: 28682564
    [Abstract] [Full Text] [Related]

  • 4. Rare genetic variant in the CFB gene presenting as atypical hemolytic uremic syndrome and immune complex diffuse membranoproliferative glomerulonephritis, with crescents, successfully treated with eculizumab.
    Alfakeeh K, Azar M, Alfadhel M, Abdullah AM, Aloudah N, Alsaad KO.
    Pediatr Nephrol; 2017 May 19; 32(5):885-891. PubMed ID: 28210841
    [Abstract] [Full Text] [Related]

  • 5. Novel Complement Factor B Gene Mutation Identified in a Kidney Transplant Recipient with a Shiga Toxin-Triggered Episode of Thrombotic Microangiopathy.
    Korzycka J, Pawłowicz-Szlarska E, Masajtis-Zagajewska A, Nowicki M.
    Am J Case Rep; 2022 Oct 28; 23():e936565. PubMed ID: 36306276
    [Abstract] [Full Text] [Related]

  • 6. Mutation of complement factor B causing massive fluid-phase dysregulation of the alternative complement pathway can result in atypical hemolytic uremic syndrome.
    Zhang Y, Kremsdorf RA, Sperati CJ, Henriksen KJ, Mori M, Goodfellow RX, Pitcher GR, Benson CL, Borsa NG, Taylor RP, Nester CM, Smith RJH.
    Kidney Int; 2020 Nov 28; 98(5):1265-1274. PubMed ID: 32540405
    [Abstract] [Full Text] [Related]

  • 7. A novel mutation in the complement factor B gene (CFB) and atypical hemolytic uremic syndrome.
    Tawadrous H, Maga T, Sharma J, Kupferman J, Smith RJ, Schoeneman M.
    Pediatr Nephrol; 2010 May 28; 25(5):947-51. PubMed ID: 20108004
    [Abstract] [Full Text] [Related]

  • 8. Genetics of atypical hemolytic uremic syndrome (aHUS).
    Rodríguez de Córdoba S, Hidalgo MS, Pinto S, Tortajada A.
    Semin Thromb Hemost; 2014 Jun 28; 40(4):422-30. PubMed ID: 24799305
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.
    Xie L, Nester CM, Reed AI, Zhang Y, Smith RJ, Thomas CP.
    Transplant Proc; 2012 Dec 28; 44(10):3037-40. PubMed ID: 23195022
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.